Skip to content

Clinical trials

Phase 2 Sarcoma trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sarcoma Phase: Phase 2 Country / region: Germany Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20041
20052
20073
20083
20102
20111
20121
20131
20141
20154
20171
20182
20191
20201
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated4
Unknown status3
Active, not recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Heidelberg University3
Hoffmann-La Roche3
University Hospital Tuebingen3
European Organisation for Research and Treatment of Cancer - EORTC2
Ludwig-Maximilians - University of Munich2
AIO-Studien-gGmbH1
Bayer1
Bristol-Myers Squibb1
Charite University, Berlin, Germany1
Cooperative Weichteilsarkom Study Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sarcoma29
Rhabdomyosarcoma4
Sarcoma, Synovial4
Leiomyosarcoma3
Neoplasms3
Breast Neoplasms2
Carcinoma, Non-Small-Cell Lung2
Colorectal Neoplasms2
Fibrosarcoma2
Hemangiosarcoma2

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.